Differential α1-adrenoceptor labeling by []prazosin and []tamsulosin

作者: Martin C Michel , Mark Goepel

DOI: 10.1016/S0014-2999(97)01419-2

关键词:

摘要: The radioligand binding properties of [3H]prazosin and [3H]tamsulosin at alpha1-adrenoceptors several rat tissues, human prostate cloned alpha1-adrenoceptor subtypes were compared in Tris/EDTA buffer unless otherwise indicated. affinity tissue alpha1A- alpha1B-adrenoceptors was somewhat greater smaller, respectively, than that [3H]prazosin. In most tissues alpha1B-adrenoceptors, had a smaller Bmax Studies with liver showed this due to considerably poorer labeling agonist low sites, while both radioligands detected similar numbers high sites. Statistically significant differences the number sites for ligands not HEPES or glycylglycine buffer, as detectable receptor tended be greater, these buffer. Among labeled fewer alpha1B- but more alpha1D-adrenoceptors. We conclude do detect same under variety conditions. This should taken into account interpretation data obtained either radioligand.

参考文章(20)
D. B. Bylund, M. L. Toews, Radioligand binding methods: practical guide and tips American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 265, ,(1993) , 10.1152/AJPLUNG.1993.265.5.L421
M Raulf, T Otto, M C Michel, W Erdbrügger, Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines. Journal of Pharmacology and Experimental Therapeutics. ,vol. 273, pp. 1287- 1294 ,(1995)
J D Deupree, D B Bylund, K A Hinton, D R Cerutis, Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 1215- 1227 ,(1996)
K Honda, M Takanashi, H Yazawa, K Sudoh, O Inagaki, Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand. Journal of Pharmacology and Experimental Therapeutics. ,vol. 263, pp. 201- 206 ,(1992)
T. M. Laz, C. Forray, T. A. Branchek, P. J.-J. Vaysse, K. E. Smith, R. L. Weinshank, J. A. Bard, The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype. Molecular Pharmacology. ,vol. 46, pp. 414- 422 ,(1994)
S. Yamada, C. Tanaka, T. Ohkura, R. Mori, R. Kimura, O. Inagaki, K. Honda, K. Kawabe, High-affinity specific [ 3 H]tamsulosin binding to α 1 in human prostates with benign prostatic hypertrophy Urological Research. ,vol. 22, pp. 273- 278 ,(1994) , 10.1007/BF00297194
Robert Gaivin, Robert M. Graham, Dianne M Perez, Michael T. Piascik, Niveen Malik, Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Molecular Pharmacology. ,vol. 46, pp. 823- 831 ,(1994)
Horst Lemoine, Bernhard Ehle, Alberto J. Kaumann, Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 331, pp. 40- 51 ,(1985) , 10.1007/BF00498850
J W Lomasney, S Cotecchia, W Lorenz, W Y Leung, D A Schwinn, T L Yang-Feng, M Brownstein, R J Lefkowitz, M G Caron, Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. Journal of Biological Chemistry. ,vol. 266, pp. 6365- 6369 ,(1991) , 10.1016/S0021-9258(18)38126-2
D J Parry-Smith, M D Fidock, N P Worman, D A Schwinn, S Campbell, S O Page, K H Wilson, G I Johnston, M J Mosley, L M Furness, Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. Journal of Pharmacology and Experimental Therapeutics. ,vol. 272, pp. 134- 142 ,(1995)